TB control in India in the COVID era

COVID-19 pandemic has disturbed the delivery of health care in almost all countries of the world. This has affected mostly the public health control programs. Because of lock downs, restrictions in movement, psychological fear of contacting the disease in health care facilities, diversion of health...

Descripción completa

Detalles Bibliográficos
Autor principal: Behera, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452904/
https://www.ncbi.nlm.nih.gov/pubmed/33641833
http://dx.doi.org/10.1016/j.ijtb.2020.08.019
_version_ 1783575253761392640
author Behera, D.
author_facet Behera, D.
author_sort Behera, D.
collection PubMed
description COVID-19 pandemic has disturbed the delivery of health care in almost all countries of the world. This has affected mostly the public health control programs. Because of lock downs, restrictions in movement, psychological fear of contacting the disease in health care facilities, diversion of health care workers for containment and management of COVID-19, utilization of diagnostic facilities like CBNAAT machines for COVID work, conversion of hospitals for care of these patients, financial diversion etc has created issues in the NTEP to focuss on TB control in India. Case notification and other areas of the program to achieve End TB by 2025 have suffered. Various ways of overcoming these difficulties have been discussed.
format Online
Article
Text
id pubmed-7452904
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74529042020-08-28 TB control in India in the COVID era Behera, D. Indian J Tuberc Viewpoint COVID-19 pandemic has disturbed the delivery of health care in almost all countries of the world. This has affected mostly the public health control programs. Because of lock downs, restrictions in movement, psychological fear of contacting the disease in health care facilities, diversion of health care workers for containment and management of COVID-19, utilization of diagnostic facilities like CBNAAT machines for COVID work, conversion of hospitals for care of these patients, financial diversion etc has created issues in the NTEP to focuss on TB control in India. Case notification and other areas of the program to achieve End TB by 2025 have suffered. Various ways of overcoming these difficulties have been discussed. Tuberculosis Association of India. Published by Elsevier B.V. 2021-01 2020-08-28 /pmc/articles/PMC7452904/ /pubmed/33641833 http://dx.doi.org/10.1016/j.ijtb.2020.08.019 Text en © 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Viewpoint
Behera, D.
TB control in India in the COVID era
title TB control in India in the COVID era
title_full TB control in India in the COVID era
title_fullStr TB control in India in the COVID era
title_full_unstemmed TB control in India in the COVID era
title_short TB control in India in the COVID era
title_sort tb control in india in the covid era
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452904/
https://www.ncbi.nlm.nih.gov/pubmed/33641833
http://dx.doi.org/10.1016/j.ijtb.2020.08.019
work_keys_str_mv AT beherad tbcontrolinindiainthecovidera

Ejemplares similares